Phase II study of blinatumomab and concurrent oral tyrosine kinase inhibitor therapy as consolidation and maintenance therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following chemotherapy-sparing induction Meeting Abstract
| Authors: | Geyer, M. B.; King, A. C.; O'Brien, J. C.; Park, J. H. |
| Abstract Title: | Phase II study of blinatumomab and concurrent oral tyrosine kinase inhibitor therapy as consolidation and maintenance therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia following chemotherapy-sparing induction |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607205603186 |
| DOI: | 10.1182/blood-2020-137016 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 45 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work